Patient Guide: Understanding Bortezomib (Velcade) 3.5mg Injection
Bortezomib (marketed under the brand name Velcade) is a targeted therapy used primarily in the treatment of multiple myeloma and mantle cell lymphoma. As a proteasome inhibitor, it works by blocking specific proteins in cancer cells, which prevents them from growing and eventually leads to cell death. If your oncologist has prescribed Bortezomib, understanding the […]
Patient Guide: Understanding Bortezomib (Velcade) 3.5mg Injection Read More »


